Creative Medical Technology Holdings, Inc. Interest on Convertible Debt, Net of Tax
Creative Medical Technology Holdings, Inc. (CELZ) reported Interest on Convertible Debt, Net of Tax of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Notes
us-gaap:InterestOnConvertibleDebtNetOfTax · last filed 2022-11-10
- Creative Medical Technology Holdings, Inc. interest on convertible debt, net of tax for the quarter ending 2021-12-31 was $0.00.
- Creative Medical Technology Holdings, Inc. interest on convertible debt, net of tax for the quarter ending 2021-09-30 was -$117.65K, a 516.78% decline year-over-year.
- Creative Medical Technology Holdings, Inc. interest on convertible debt, net of tax for the quarter ending 2021-06-30 was $63.93K, a 368.50% increase year-over-year.
- Creative Medical Technology Holdings, Inc. interest on convertible debt, net of tax for the quarter ending 2021-03-31 was $53.72K, a 8.05% increase year-over-year.
- Creative Medical Technology Holdings, Inc. interest on convertible debt, net of tax for fiscal 2021 was $0.00.
| Period end | Interest on Convertible Debt, Net of Tax 3 month | Interest on Convertible Debt, Net of Tax 6 month | Interest on Convertible Debt, Net of Tax 9 month | Interest on Convertible Debt, Net of Tax 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$117.65K derived: sum of 2 quarters · filed 2022-11-10 | -$53.72K derived: sum of 3 quarters · filed 2022-11-10 | $0.00 10-K · filed 2022-03-30 |
| 2021-09-30 | -$117.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$53.72K derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $63.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $117.65K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $53.72K 10-Q · filed 2022-05-13 | |||
| 2020-09-30 | $28.23K 10-Q · filed 2021-11-15 | $41.87K derived: sum of 2 quarters · filed 2021-11-15 | $105.34K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $13.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $63.36K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $49.71K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |